With changes in Medicaid eligibility looming, hospitals must plan now to keep patient care gaps at bay.
|Videos|December 9, 2014
How to Manage the High Cost of Specialty Drugs
Raulo Frear, PharmD, general manager of OmedaRx, discusses effective strategies to ensure patients gain access to high cost specialty medications.
Advertisement
Raulo Frear, PharmD, general manager of OmedaRx, discusses effective strategies to ensure patients gain access to high cost specialty medications.
Advertisement
Related to this article
Apitegromab-mstn is cleared as an add-on to SMN2-targeted treatment for patients aged 2 and older, directly addressing muscle loss.
Once-daily oral deucrictibant extended-release significantly reduced hereditary angioedema attacks compared with placebo in the pivotal phase 3 CHAPTER-3 trial.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Adult Pneumococcal Immunizations: A Practical Guide for Pharmacists
2
How Pharmacists Overcome PCSK9 Inhibitor Access Barriers
3
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
4
Beyond Cost Avoidance: Advancing Unit-Level Pharmaceutical Economics in Health Systems
5